Acumen Pharmaceuticals, Inc.

Q2 2024 13F Holders

Symbol
ABOS
CUSIP
00509G209
Type
Equity
Class
COM
Num filings
89
Total reported value, excl. options
$106 M
Manager Report Date Value ($000) Shares Option Type